ArticlePDF Available

Carrier Frequency of Congenital Leptin Deficiency in Central Punjab Region of Pakistan

Authors:

Abstract and Figures

Congenital leptin deficiency is a rare autosomal recessive disorder, characterized by hyperphagia and early onset obesity. Worldwide data on this disorder includes only 25 cases out of this only six pathogenic mutations have been reported in the leptin gene. Most of these cases have been reported in Central Punjab region of Pakistan, harboring a (p.Gly133fsX145) mutation in homozygous state. This mutation has founder effect in Arain caste from Central Punjab region of Pakistan. In this study, carrier frequency of (p.Gly133fsX145) mutation was determined in 50 individuals belonging to Arain caste. Analysis of amplicons contains p.Gly133fsX145 mutation were analyzed by different techniques such as SSCP, Heteroduplex analysis and sequencing. Mutation was not found in any individual studied. This finding suggests that frequency of (p.Gly133fsX145) mutation in Arain caste is not as higher as its predicted founder effect in congenitally obese children of this caste was anticipated.
Content may be subject to copyright.
Carrier Frequency of Congenital Leptin Deficiency in Central Punjab Region of
Pakistan
Muhammad Wasim* and Nida Fakhar
Institute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences Lahore, Pakistan
*Corresponding author: Muhammad Wasim, Institute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences, Lahore, Pakistan, Tel:
923224990977; E-mail: mm.waseemjee@gmail.com
Received date: March 24, 2015; Accepted date: April 25, 2015; Published date: April 30, 2015
Copyright: © 2015 Wasim M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Congenital leptin deficiency is a rare autosomal recessive disorder, characterized by hyperphagia and early onset
obesity. Worldwide data on this disorder includes only 25 cases out of this only six pathogenic mutations have been
reported in the leptin gene. Most of these cases have been reported in Central Punjab region of Pakistan, harboring
a (p.Gly133fsX145) mutation in homozygous state. This mutation has founder effect in Arain caste from Central
Punjab region of Pakistan. In this study, carrier frequency of (p.Gly133fsX145) mutation was determined in 50
individuals belonging to Arain caste. Analysis of amplicons contains p.Gly133fsX145 mutation were analyzed by
different techniques such as SSCP, Heteroduplex analysis and sequencing. Mutation was not found in any individual
studied. This finding suggests that frequency of (p.Gly133fsX145) mutation in Arain caste is not as higher as its
predicted founder effect in congenitally obese children of this caste was anticipated.
Keywords: Congenital leptin deficiency; Hyperphagia; SSCP;
Heteroduplex analysis; p.Gly133fsX145
Introduction
Leptin is a 16-kDa adipocytokine or adipokine hormone which has
167 amino acids [1]. Firstly discovered in mice in 1994, the gene is
known as Ob and the mutated mice known as Ob/Ob mice [2].
Mutation in leptin gene of Ob/Ob mice was first explained in the
1950s, a morbidly obese phenotype is caused by spontaneous mutation
due to more eating habit and less energy expenditure [3].
Circulating leptin level decrease during fasting and increase during
feeding, which indicates that leptin is a physiological signal for
transition between the states of energy adequacy and starvation [4,5].
Role of this hormonal protein is like a satiety factor and it helps in
regulating energy balance. It regulates the reproductive,
hematopoietic, and immune systems. It is involved in development of
brain and modulation of carbohydrate metabolism [6]. The most
important pathway is leptin-melanocortin pathway presently known
to be involved in five congenital forms of monogenic obesity [7].
Leptin is a neurotransmitter which acts via two populations of
arcuate (Arc) neurons located in the hypothalamus. The first group of
neurons expresses Agouti-related Peptide (AgRP) and Neuropeptide Y
(NPY) and the second one expresses Pro-Opio-Melano-Cortin
(POMC) and Cocaine and Amphetamine-Related Transcript (CART).
Leptin acts on POMC/CART neurons to signal repletion of energy
stores and thereby causes suppression of food intake and increase in
energy expenditure. The action of leptin on AgRP/NPY neurons is
inhibitory and their activation through fasting increases food intake
and energy conservation [7,8]. Congenital leptin deficiency is caused
by mutations in the leptin gene that cause obesity. Until now only 6
pathogenic leptin mutations have been reported.
The first homozygous mutation was (p.Gly133fsX145) detected in
the leptin gene of two Pakistani cousins who had undetectable serum
leptin level [9]. The second leptin mutation (R105W) was identified in
4 members of a Turkish family (Strobel et al. 1998), the third (N103K)
in 2 Egyptian children [10] and the fourth (L72S) in an Austrian 14
years old female child [11]. Fifth and sixth mutations were
(p.Leu161fsX170 and c.104_106delTCA) in obese children of Pakistan
[12]. Congenital leptin deficiency has a pleiotropic effect and also
associated with multiple disorders such as deregulation of
reproductive, immune, neuroendocrine and metabolic physiology
[9,13-15].
Most of the reported cases of congenital leptin deficiency had
Pakistani origin; the disorder might be a frequent cause of morbid
childhood obesity in Pakistan, based on higher rates of
consanguineous marriages in Central Punjab [12]. Except two of these
cases, all harbored (p.Gly133fsX145) mutation in Arain caste
indicating founder effect. Therefore the present study was designed to
determine the carrier frequency of (p.Gly133fsX145) mutation in 50
normal individuals from the Central Punjab belonging to Arain caste.
Experimental Methodology
Blood samples were collected from 50 individuals belonging to
Arain caste. Information on demography, birth and developmental
history, dietary habits and physical activity were collected. Body Mass
Index (BMI=kg/m2) was measured in the standard way as shown in
Figure 1.
Obesity & Weight Loss Therapy
Wasim and Fakhar, J Obes Weight Loss Ther
2015, 5:2
http://dx.doi.org/10.4172/2165-7904.1000260
Research Article Open Access
J Obes Weight Loss Ther
ISSN:2165-7904 JOWT, an open access journal Volume 5 • Issue 2 • 1000260
Figure 1: Graphical presentation of sampling data based on age and BMI.
Exon 3 of the leptin gene (NG_007450.1) was amplified using a
primer pair SeqF: GAACCTCCGGGATCTTCTTC and SeqR:
CACCTCTGTGGAGTAGCCTGA. The product amplified by this pair
was 127 bp. Each 25 μl PCR reaction included 50 ng DNA, 1×Taq
buffer, 2 mM MgCl2, 200 μM of each dNTP, 10 pmoles of each primer
and 5 U/µl of Taq DNA polymerase.
DNA was initially denatured at 95°C for 5 min and then the desired
fragments were amplified using 35 cycles of denaturation at 94°C for
45 sec, annealing at 60°C for 45 sec, and extension at 72°C for 1 min
followed by a 10 min step of final extension at 72°C.
The amplicons were detected on agarose gel along with 1 μl of
molecular weight marker of 1 Kb size Figure 2. Different techniques
were used to find out mutations in the amplified fragment of leptin
gene. PAGE was done for Single Stranded Conformation
Polymorphism and Heteroduplex analysis described by Cambrex Bio
Science Rockland, Inc 2003. Sequencing was performed by Sanger
dideoxy chain termination method.
Figure 2: Gel electrophoresis for PCR products (LEP gene) amplified by SeqR/SeqF primers. Samples showing amplification of 127 bp
fragment in comparison with 250 bp in 1 Kb ladder.
Results
For SSCP analysis, 5 µl (amplified products were added to 15 µl of
stop solution (95% formamide, 10 mM NaOH and 0.05%
bromophenol blue). The PCR samples were heat-denatured at 95°C for
5 min and chilled on ice immediately for 5 min, and loaded onto a 10%
PAGE for 6-7 hours (Figure 3).
To validate the results of SSCP, heteroduplex analysis was
performed. The normal 5 µl and mutant 5 µl samples were mixed and
denatured at 95°C for 5 min in Thermo-cycler by following the step of
30 min at 37°C and then added 3 µl bromophenol dye. At the end,
products were loaded onto a 10% PAGE (Figure 4).
Citation: Wasim M, Fakhar N (2015) Carrier Frequency of Congenital Leptin Deficiency in Central Punjab Region of Pakistan. J Obes Weight
Loss Ther 5: 260. doi:10.4172/2165-7904.1000260
Page 2 of 5
J Obes Weight Loss Ther
ISSN:2165-7904 JOWT, an open access journal Volume 5 • Issue 2 • 1000260
Figure 3: PAGE for SSCP polymorphism of PCR product. No mutation found in all the samples after comparison with standard samples;
(Normal (N), Standard (S), Mutant (M)).
Figure 4: PAGE for heteroduplex analysis. Last four bands show more width as compared to first two. That shows mutation is present in
standard samples. Mutation shown in the figure confirms that technique is valid which was used for all the samples; (Normal (N), Standard
(S)).
Citation: Wasim M, Fakhar N (2015) Carrier Frequency of Congenital Leptin Deficiency in Central Punjab Region of Pakistan. J Obes Weight
Loss Ther 5: 260. doi:10.4172/2165-7904.1000260
Page 3 of 5
J Obes Weight Loss Ther
ISSN:2165-7904 JOWT, an open access journal Volume 5 • Issue 2 • 1000260
For more confirmation some of these samples were sequenced and
analyzed with the help of Chromas software. Analysis showed that
mutation (deletion of G) was present in the 6 G stretch of the standard
sample but not in studied normal samples as shown in Figures 5 and 6.
Figure 5: Chromatogram of standard mutated sequence.
Figure 6: Chromatogram of normal leptin gene sequence.
Discussion
Morbid congenital obesity is less likely to be passed unnoticed at
social level. The present study, the leptin gene is employed for its
mutational analysis. The samples were taken from the obese persons
specifically of Arain caste.
Figure 7: Graphical data of different countries based on BMI ratio.
The objective of this study was to genetically characterize the leptin
gene to identify the SNPs as future biomarkers for the early diagnosis
of Congenital Obesity Disease. Another objective of the present study
was to determine carrier frequency of (p.Gly133fsX145) mutation in
50 individual of Arain caste. According to sequence analysis, no
mutation was present in the leptin gene in all the samples analyzed.
Graphical data shows BMI ratio of different countries compared with
Pakistan as shown in Figure 7 indicating that BMI ratio is higher in
Pakistan, compared with most of the countries.
Mutation/polymorphism is present in the LEP gene at the 5’ region.
This mutation is G-2548A. This polymorphism was related with
extreme obesity in women. It was observed that G-2548 allele was
present more frequently in the overweight subjects as compared to
normal subjects. Variations at the leptin are associated with frequent
obesity phenotypes including morbid obesity disease [16].
Conclusion
Conclusively, the absence of (p.Gly133fsX145) mutation in 50
individuals of Arain caste indicates that the frequency of this mutation
is not as higher as its predicted founder effect in congenitally obese
Pakistani children of this caste was anticipated.
References
1. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000)
Central nervous system control of food intake. Nature 404: 661-671.
2. Myers MG, Cowley MA, Münzberg H (2008) Mechanisms of leptin
action and leptin resistance. Annu Rev Physiol 70: 537-556.
Citation: Wasim M, Fakhar N (2015) Carrier Frequency of Congenital Leptin Deficiency in Central Punjab Region of Pakistan. J Obes Weight
Loss Ther 5: 260. doi:10.4172/2165-7904.1000260
Page 4 of 5
J Obes Weight Loss Ther
ISSN:2165-7904 JOWT, an open access journal Volume 5 • Issue 2 • 1000260
3. Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, et al.
(2003) Serum adiponectin levels are inversely associated with overall and
central fat distribution but are not directly regulated by acute fasting or
leptin administration in humans: cross-sectional and interventional
studies. J Clin Endocrinol Metab 88: 4823-4831.
4. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, et al. (1996)
Role of leptin in the neuroendocrine response to fasting. Nature 382:
250-252.
5. Flier JS (1998) Clinical review 94: What's in a name? In search of leptin's
physiologic role. J Clin Endocrinol Metab 83: 1407-1413.
6. Pasco JA, Henry MJ, Kotowicz MA, Collier GR, Ball MJ, et al. (2001)
Serum leptin levels are associated with bone mass in nonobese women. J
Clin Endocrinol Metab 86: 1884-1887.
7. Farooqi IS (2005) Genetic and hereditary aspects of childhood obesity.
Best Pract Res Clin Endocrinol Metab 19: 359-374.
8. Coll AP, Farooqi IS, O'Rahilly S (2007) The hormonal control of food
intake. Cell 129: 251-262.
9. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, et al. (1997)
Congenital leptin deficiency is associated with severe early-onset obesity
in humans. Nature 387: 903-908.
10. Mazen I, El-Gammal M, Abdel-Hamid M, Amr K (2009) A novel
homozygous missense mutation of the leptin gene (N103K) in an obese
Egyptian patient. Mol Genet Metab 97: 305-308.
11. Fischer-Posovszky P, von Schnurbein J, Moepps B, Lahr G, Strauss G, et
al. (2010) A new missense mutation in the leptin gene causes mild obesity
and hypogonadism without affecting T cell responsiveness. J Clin
Endocrinol Metab 95: 2836-2840.
12. Fatima W, Shahid A, Imran M, Manzoor J, Hasnain S, et al. (2011) Leptin
deficiency and leptin gene mutations in obese children from Pakistan. Int
J Pediatr Obes 6: 419-427.
13. Farooqi IS (2008) Monogenic human obesity. Front Horm Res 36: 1-11.
14. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, et al. (2002)
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and
neuroendocrine/metabolic dysfunction of human congenital leptin
deficiency. J Clin Invest 110:1093–1103.
15. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD (1998) A leptin
missense mutation associated with hypogonadism and morbid obesity.
Nat Genet 18: 213-215.
16. Mammès O, Betoulle D, Aubert R, Herbeth B, Siest G, et al. (2000)
Association of the G-2548A polymorphism in the 5' region of the LEP
gene with overweight. Ann Hum Genet 64: 391-394
Citation: Wasim M, Fakhar N (2015) Carrier Frequency of Congenital Leptin Deficiency in Central Punjab Region of Pakistan. J Obes Weight
Loss Ther 5: 260. doi:10.4172/2165-7904.1000260
Page 5 of 5
J Obes Weight Loss Ther
ISSN:2165-7904 JOWT, an open access journal Volume 5 • Issue 2 • 1000260
... Until know 6 pathogenic mutations reported in the leptin gene that are associated with congenital leptin deficiency. These mutations are; (the first homozygous mutation was (p.Gly133fsX145) detected in two Pakistani cousins [9], second mutation (R105W) was identified in 4 members of a Turkish family [10], third (N103K) in 2 Egyptian children [11], fourth (L72S) in an Austrian female child [12], fifth and sixth mutations were (p.Leu161fsX170 and c.104_106delTCA) in obese children of Pakistan [4,13]. These mutations are basically reported in obese individuals. ...
... Potentially, leptin therapy could sustain weight loss by overriding the tendency toward energy conservation [16]. In the above it is mentioned that six pathogenic mutations were found in leptin gene that's showed leptin gene involved in the obesity and leanness [13]. ...
Article
Full-text available
Obesity and leanness are the medical conditions in which excess and deficient body fat present respectively. It may have an adverse effect on health, leading to reduced life expectancy and increased health problems. Environmental factors, especially increased consumption of high caloric diet, are considered responsible for the obesity epidemic, although genetic factors also contribute dysregulation of food consumption. Leptin gene may have an effect on the obesity and leanness because six pathogenic mutations already reported in leptin gene. Leptin gene mutations have a vital role to cause different types of cancers.
... To date ,only four pathogenic leptin mutations have been reported in obese children .The first mutation(p.Gly133fsX145) was detected in the leptin gene of two pakistani cousin with undetectable serum leptin levels.The second(R105W)was identified in four members of Turkish family(Wasim & Fakhar, 2015)(Strobel et al.,1998. The third(N.103K) in two Egyptian children(Mazen, El-Gammal, Abdel-Hamid, & Amr, 2009).The fourth(L72S) in a 14-year old female Austraian child(Fatima, et al., 2011).To study the sequence variant c.309C>A resulting in to single amino acid substitution p.N103K. ...
Article
Full-text available
Obesity and its associated health complications is a huge health burden worldwide. Genetic factors play a crucial role in determining an individual's predisposition to the weight gain and being obese.Leptin, a key appetite-regulating hormone derived from the white adipose tissue, Journal of Xi'an Shiyou University, Natural Science Edition ISSN: 1673-064X http://xisdxjxsu.asia VOLUME 19 ISSUE 05 MAY 2023 408-424 primarily acts on hypothalamic neurons to activate catabolic pathway and inhibit anabolic pathway, which can result in anorexia and weight reduction.Congenital leptin deficiency is a autosomal recessive disease characterised by hyperphagia and early-onset obesity.Genome wide association studies (GWAS) approach and their findings signified a number of genetic variants predisposing to obesity, which further needs the insilico analysis to confirm the damaging effect on protein structure and function. A missense variant (c.309C>A; p.N103K) in LEPTIN gene in Egyptian child, identified through Whole exome sequencing was selected form the literature for In Silico analysis. The pathogenicity of the variant was evaluated through computational tools including Mupro, Predict, Fathmm, provean, SNAP2. additionally, the secondary structure of the normal protein and solvent accessibility were checked through RaptorX tools. The 3-Dimensional Structure was constructed via biovia discovery studio. The energy minimization of mutant structure was carried out by SWISS PDB Viewer. In the present study, Molecular Docking were performed which predicted that there is drastic decrease in the stability of the mutant protein. The energy calculation also revealed that there is a difference of kj/mol which also indicates that the variant has significantly decreased the stability of protein consequently resulting in obesity.
... Hypothalamic neuropeptide Y and leptin hormone are essential for the energy homeostasis in the body (Kalra 2007). Congenital leptin deficiency is a rare cause of severe early-onset obesity (Frank et al. 2013;Wabitsch et al. 2015;Wasim and Fakhar 2015). In 1994, LEP gene was firstly discovered in mice (Zhang et al. 1994, Friedman 2010; the gene is also known as Ob gene owing to its relevance to obesity. ...
Article
Full-text available
Abstract Leptin protein consists of 167 amino acids, which is mainly secreted from the white adipose tissue. This protein acts on the hypothalamic regions of the brain which control eating behavior, thus playing a significant role in maintaining body’s metabolism. Leptin receptors belong to glycoprotein 130 (gp130) family of cytokine receptors and exist in six isoforms (LEPR a–f), and all the isoforms are encoded by LEPR gene; out of these isoforms, the LEPR-b receptor is the ‘longest form,’ and in most of the cases, mutations in this isoform cause severe obesity. Also, mutations in the leptin gene (LEP) or its receptors gene can lead to obesity. Some biochemical pathways affect the bioactivity of leptin and/or its receptors. To date, eleven pathogenic mutations have been reported in the LEP which are p.L72S, p.N103K, p.R105W, p.H118L, p.S141C, p.W121X c.104_106delTCA, c.135del3bp, c.398delG, c.481_482delCT, and c.163C>T. Different mutations in the LEPR have also been reported as c.2396-1 G>T, c.1675 G>A, p.P316T, etc. In some studies, where leptin was deficient, leptin replacement therapy has shown positive impact by preventing weight gain and obesity.
Article
Full-text available
Congenital leptin deficiency is a rare human genetic condition clinically characterized by hyperphagia and acute weight gain usually during the first postnatal year. The worldwide data on this disorder includes only 14 cases and four pathogenic mutations have been reported in the leptin gene. The objectives of this study were to measure serum leptin levels in obese children and to detect leptin gene mutations in those found to be leptin deficient. A total of 25 obese children were recruited for the study. Leptin deficiency was detected in nine of them. Leptin gene sequencing identified mutations in homozygous state in all the leptin deficient children. Two cases carried novel mutations (c.481_482delCT and c.104_106delTCA) and each of the remaining seven the previously reported frameshift mutation (c.398delG). The results suggest that leptin deficiency caused by mutations in the leptin gene may frequently be seen in obese Pakistani children from Central Punjab.
Article
Full-text available
Leptin, a protein product of adipocytes, plays a critical role in the regulation of body weight, immune function, pubertal development, and fertility. So far, only three homozygous mutations in the leptin gene in a total of 13 individuals have been found leading to a phenotype of extreme obesity with marked hyperphagia and impaired immune function. Serum leptin was measured by ELISA. The leptin gene (OB) was sequenced in patient DNA. The effect of the identified novel mutation was assessed using HEK293 cells. We describe a 14-yr-old child of nonobese Austrian parents without known consanguinity. She had a body mass index of 31.5 kg/m(2) (+2.46 SD score) and undetectable leptin serum levels. Sequencing of the leptin gene revealed a hitherto unknown homozygous transition (TTA to TCA) in exon 3 of the LEP gene resulting in a L72S replacement in the leptin protein. RT-PCR, Western blot, and immunohistochemical analysis indicated that the mutant leptin was expressed in the patient's adipose tissue but retained within the cell. Using a heterologous cell system, we confirmed this finding and demonstrated that the side chain of Leu72 is crucial for intracellular leptin trafficking. Our patient showed signs of a hypogonadotropic hypogonadism. However, in contrast to the literature, she showed only mild obesity and a normal T cell responsiveness. These findings shed a new light on the clinical consequences of leptin deficiency. Congenital leptin deficiency should be considered possible in pediatric patients with mild obesity even if parents are lean and unrelated.
Article
Full-text available
New information regarding neuronal circuits that control food intake and their hormonal regulation has extended our understanding of energy homeostasis, the process whereby energy intake is matched to energy expenditure over time. The profound obesity that results in rodents (and in the rare human case as well) from mutation of key signalling molecules involved in this regulatory system highlights its importance to human health. Although each new signalling pathway discovered in the hypothalamus is a potential target for drug development in the treatment of obesity, the growing number of such signalling molecules indicates that food intake is controlled by a highly complex process. To better understand how energy homeostasis can be achieved, we describe a model that delineates the roles of individual hormonal and neuropeptide signalling pathways in the control of food intake and the means by which obesity can arise from inherited or acquired defects in their function.
Article
We and others have identified several single gene defects that disrupt the molecules in the leptinmelanocortin pathway causing severe obesity in humans. In this review, we consider these human monogenic obesity syndromes and discuss how far the characterisation of these patients has informed our understanding of the physiological role of leptin and the melanocortins in the regulation of human body weight and neuroendocrine function.
Article
Congenital leptin deficiency is a rare recessive genetic disorder resulting in severe hyperphagia and early onset obesity. It is caused by mutations in the LEP gene encoding leptin. To date, only two mutations have been identified in the LEP gene, Δ133G and R105W. We present the third reported mutation identified in an Egyptian patient with very low serum leptin levels and severe early onset obesity (BMI = 51). Direct sequencing of the coding region of the LEP gene revealed a novel homozygous missense mutation, N103K. The N103K mutation was not found in 100 alleles from 50 unrelated Egyptian normal-weight control subjects using polymerase chain reaction and restriction fragment length polymorphism analysis. In conclusion, this study presents the third reported mutation of the LEP gene and will provide further insight into the physiologic role of leptin in human obesity.
Article
A total deficiency in or resistance to the protein leptin causes severe obesity. As leptin levels rise with increasing adiposity in rodents and man, it is proposed to act as a negative feedback 'adipostatic signal' to brain centres controlling energy homeostasis, limiting obesity in times of nutritional abundance. Starvation is also a threat to homeostasis that triggers adaptive responses, but whether leptin plays a role in the physiology of starvation is unknown. Leptin concentration falls during starvation and totally leptin-deficient ob/ob mice have neuroendocrine abnormalities similar to those of starvation, suggesting that this may be the case. Here we show that preventing the starvation-induced fall in leptin with exogenous leptin substantially blunts the changes in gonadal, adrenal and thyroid axes in male mice, and prevents the starvation-induced delay in ovulation in female mice. In contrast, leptin repletion during this period of starvation has little or no effect on body weight, blood glucose or ketones. We propose that regulation of the neuroendocrine system during starvation could be the main physiological role of leptin.
Article
The extreme obesity of the obese (ob/ob) mouse is attributable to mutations in the gene encoding leptin, an adipocyte-specific secreted protein which has profound effects on appetite and energy expenditure. We know of no equivalent evidence regarding leptin's role in the control of fat mass in humans. We have examined two severely obese children who are members of the same highly consanguineous pedigree. Their serum leptin levels were very low despite their markedly elevated fat mass and, in both, a homozygous frame-shift mutation involving the deletion of a single guanine nucleotide in codon 133 of the gene for leptin was found. The severe obesity found in these congenitally leptin-deficient subjects provides the first genetic evidence that leptin is an important regulator of energy balance in humans.
Article
Mutations in the translated part of the leptin gene (LEP) have been found in only two families. Nevertheless DNA polymorphisms in the LEP region are linked to extreme obesity. We previously found in the 5' region of LEP a polymorphism, G-2548A, associated with a differerce in BMI reduction following a low calorie diet in overweight women. Recently, this polymorphism was associated with extreme obesity in women. In this work, we genotyped a new sample from the general population including 314 normal weight (BMI < 27 kg/m2) and 109 overweight subjects (BMI > or = 27 kg/m2). The genotype and allele frequencies were significantly different between groups, with the G-2548 allele being more frequent in the overweight subjects (p < 0.01). In men, carriers of this allele had lower leptin concentrations adjusted for fat mass (p = 0.05). Our results indicate that variations at the leptin locus are associated with common obesity phenotypes, and not only with extreme obesity or the rare mendelian obesity syndromes.